207 related articles for article (PubMed ID: 23241166)
1. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
2. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
3. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
Stoecklin G; Gross B; Ming XF; Moroni C
Oncogene; 2003 Jun; 22(23):3554-61. PubMed ID: 12789264
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
Leppänen T; Jalonen U; Korhonen R; Tuominen RK; Moilanen E
Eur J Pharmacol; 2010 Feb; 628(1-3):220-5. PubMed ID: 19925787
[TBL] [Abstract][Full Text] [Related]
6. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
[TBL] [Abstract][Full Text] [Related]
7. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
8. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes.
Al-Souhibani N; Al-Ahmadi W; Hesketh JE; Blackshear PJ; Khabar KS
Oncogene; 2010 Jul; 29(29):4205-15. PubMed ID: 20498646
[TBL] [Abstract][Full Text] [Related]
9. Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells.
Suswam E; Li Y; Zhang X; Gillespie GY; Li X; Shacka JJ; Lu L; Zheng L; King PH
Cancer Res; 2008 Feb; 68(3):674-82. PubMed ID: 18245466
[TBL] [Abstract][Full Text] [Related]
10. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
11. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
12. HuR post-transcriptionally regulates TNF-α-induced IL-6 expression in human pulmonary microvascular endothelial cells mainly via tristetraprolin.
Shi JX; Su X; Xu J; Zhang WY; Shi Y
Respir Physiol Neurobiol; 2012 Apr; 181(2):154-61. PubMed ID: 22426177
[TBL] [Abstract][Full Text] [Related]
13. Tristetraprolin (TTP) coordinately regulates primary and secondary cellular responses to proinflammatory stimuli.
Qiu LQ; Lai WS; Bradbury A; Zeldin DC; Blackshear PJ
J Leukoc Biol; 2015 Apr; 97(4):723-36. PubMed ID: 25657290
[TBL] [Abstract][Full Text] [Related]
14. Insulin increases tristetraprolin and decreases VEGF gene expression in mouse 3T3-L1 adipocytes.
Cao H; Urban JF; Anderson RA
Obesity (Silver Spring); 2008 Jun; 16(6):1208-18. PubMed ID: 18388887
[TBL] [Abstract][Full Text] [Related]
15. The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells.
Bros M; Wiechmann N; Besche V; Art J; Pautz A; Grabbe S; Kleinert H; Reske-Kunz AB
Mol Immunol; 2010 Feb; 47(5):1161-70. PubMed ID: 19945750
[TBL] [Abstract][Full Text] [Related]
16. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.
Ksiazkiewicz M; Gottfried E; Kreutz M; Mack M; Hofstaedter F; Kunz-Schughart LA
Immunobiology; 2010; 215(9-10):737-47. PubMed ID: 20605053
[TBL] [Abstract][Full Text] [Related]
17. Tristetraprolin suppresses AHRR expression through mRNA destabilization.
Lee HH; Kim WT; Kim DH; Park JW; Kang TH; Chung JW; Leem SH
FEBS Lett; 2013 May; 587(10):1518-23. PubMed ID: 23583445
[TBL] [Abstract][Full Text] [Related]
18. Gene transduction of tristetraprolin or its active domain reduces TNF-alpha production by Jurkat T cells.
Suzuki E; Tsutsumi A; Goto D; Matsumoto I; Ito S; Otsu M; Onodera M; Takahashi S; Sato Y; Sumida T
Int J Mol Med; 2006 May; 17(5):801-9. PubMed ID: 16596264
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tristetraprolin expression by interleukin-1 beta and dexamethasone in human pulmonary epithelial cells: roles for nuclear factor-kappa B and p38 mitogen-activated protein kinase.
King EM; Kaur M; Gong W; Rider CF; Holden NS; Newton R
J Pharmacol Exp Ther; 2009 Aug; 330(2):575-85. PubMed ID: 19435930
[TBL] [Abstract][Full Text] [Related]
20. Compounds that increase or mimic cyclic adenosine monophosphate enhance tristetraprolin degradation in lipopolysaccharide-treated murine j774 macrophages.
Jalonen U; Paukkeri EL; Moilanen E
J Pharmacol Exp Ther; 2008 Aug; 326(2):514-22. PubMed ID: 18469159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
